Medarex, Inc. (NASDAQ:MEDX.DL)

CAPS Rating: No stars

A biopharmaceutical company developing therapeutic products for cancer, inflammation, autoimmune disorders and other life-threatening and debilitating diseases based on its proprietary technology.

Featured Broker Partners


Advertisement